Study oversight
Infection
INFECTION
The University of Melbourne served as the study sponsor. The study was reviewed and approved by the Royal Melbourne Hospital Human Research Ethics Committee and was conducted under the Clinical Trial Notification (CTN) Scheme (CTN ID: 04968-1) administered by the Australian Therapeutic Goods Administration. All participants provided written informed consent prior to enrolment. The study was conducted at the Royal Melbourne Hospital (initial Lower Dose sentinels N = 6) and the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia (for all remaining participants). The study is registered at 